These findings represent a novel vicious cycle between AK4 and HIF-1α in response to hypoxic stress during lung cancer progression and highlight the therapeutic opportunity of targeting the AK4-HIF-1α axis in NSCLC. The gene discussed is HIF1A; the disease is lung cancer.